| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Defects, Congenital | 31 | 2025 | 1894 | 2.110 |
Why?
|
| Cardiac Surgical Procedures | 33 | 2025 | 1170 | 2.000 |
Why?
|
| Reoperation | 26 | 2025 | 844 | 1.550 |
Why?
|
| Postoperative Complications | 28 | 2025 | 3130 | 1.460 |
Why?
|
| Vascular Surgical Procedures | 14 | 2024 | 539 | 1.430 |
Why?
|
| Transposition of Great Vessels | 7 | 2020 | 126 | 1.410 |
Why?
|
| Heart-Assist Devices | 16 | 2023 | 991 | 1.400 |
Why?
|
| Heart Transplantation | 24 | 2024 | 832 | 1.390 |
Why?
|
| Lung Transplantation | 17 | 2023 | 350 | 1.260 |
Why?
|
| Norwood Procedures | 7 | 2024 | 103 | 1.130 |
Why?
|
| Pulmonary Artery | 10 | 2022 | 441 | 1.080 |
Why?
|
| Scimitar Syndrome | 4 | 2021 | 52 | 1.050 |
Why?
|
| Palliative Care | 10 | 2024 | 444 | 1.030 |
Why?
|
| Coronary Vessel Anomalies | 6 | 2023 | 284 | 1.030 |
Why?
|
| Aorta, Thoracic | 9 | 2024 | 536 | 1.020 |
Why?
|
| Infant | 76 | 2025 | 13306 | 1.010 |
Why?
|
| Heart Ventricles | 15 | 2022 | 769 | 1.000 |
Why?
|
| Heart Septal Defects, Ventricular | 6 | 2018 | 133 | 0.980 |
Why?
|
| Hypoplastic Left Heart Syndrome | 8 | 2024 | 276 | 0.970 |
Why?
|
| Retrospective Studies | 84 | 2025 | 17667 | 0.930 |
Why?
|
| Treatment Outcome | 65 | 2025 | 12984 | 0.910 |
Why?
|
| Discrete Subaortic Stenosis | 2 | 2024 | 7 | 0.840 |
Why?
|
| Aortic Valve | 6 | 2024 | 460 | 0.820 |
Why?
|
| Time Factors | 34 | 2025 | 6279 | 0.820 |
Why?
|
| Abnormalities, Multiple | 8 | 2018 | 974 | 0.810 |
Why?
|
| Pulmonary Veins | 4 | 2021 | 169 | 0.800 |
Why?
|
| Arterial Switch Operation | 2 | 2020 | 24 | 0.780 |
Why?
|
| Aorta | 7 | 2023 | 529 | 0.780 |
Why?
|
| Infant, Newborn | 53 | 2024 | 8589 | 0.760 |
Why?
|
| Child, Preschool | 61 | 2025 | 15057 | 0.700 |
Why?
|
| Cardiopulmonary Bypass | 12 | 2020 | 359 | 0.700 |
Why?
|
| Echocardiography | 13 | 2024 | 1138 | 0.700 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2020 | 152 | 0.680 |
Why?
|
| Heterotaxy Syndrome | 2 | 2021 | 64 | 0.680 |
Why?
|
| Pulmonary Veno-Occlusive Disease | 1 | 2021 | 28 | 0.670 |
Why?
|
| Tracheal Stenosis | 1 | 2020 | 31 | 0.660 |
Why?
|
| Vascular Ring | 1 | 2019 | 7 | 0.620 |
Why?
|
| Humans | 141 | 2025 | 131680 | 0.610 |
Why?
|
| Blalock-Taussig Procedure | 4 | 2022 | 49 | 0.600 |
Why?
|
| Cardiovascular Surgical Procedures | 2 | 2018 | 42 | 0.600 |
Why?
|
| Child | 74 | 2025 | 26299 | 0.590 |
Why?
|
| Graft Rejection | 12 | 2024 | 560 | 0.590 |
Why?
|
| Male | 87 | 2025 | 65267 | 0.570 |
Why?
|
| Fontan Procedure | 7 | 2019 | 189 | 0.570 |
Why?
|
| Aortopulmonary Septal Defect | 1 | 2018 | 4 | 0.570 |
Why?
|
| Heart Valve Prosthesis Implantation | 6 | 2020 | 440 | 0.570 |
Why?
|
| Heart Valve Prosthesis | 6 | 2020 | 303 | 0.550 |
Why?
|
| Capillaries | 1 | 2018 | 67 | 0.550 |
Why?
|
| Lung Diseases | 6 | 2023 | 400 | 0.530 |
Why?
|
| Follow-Up Studies | 27 | 2024 | 5297 | 0.520 |
Why?
|
| Female | 86 | 2025 | 71186 | 0.520 |
Why?
|
| Thoracic Surgical Procedures | 3 | 2018 | 105 | 0.510 |
Why?
|
| Heart Septal Defects | 3 | 2025 | 45 | 0.510 |
Why?
|
| Heart | 4 | 2018 | 675 | 0.500 |
Why?
|
| Aortic Coarctation | 5 | 2024 | 98 | 0.470 |
Why?
|
| Tissue and Organ Procurement | 6 | 2022 | 253 | 0.450 |
Why?
|
| Bioprosthesis | 5 | 2020 | 112 | 0.440 |
Why?
|
| Graft Survival | 9 | 2017 | 466 | 0.440 |
Why?
|
| Risk Factors | 28 | 2025 | 10959 | 0.430 |
Why?
|
| Adolescent | 51 | 2025 | 20982 | 0.420 |
Why?
|
| Length of Stay | 14 | 2024 | 1399 | 0.410 |
Why?
|
| Hospital Mortality | 9 | 2025 | 1075 | 0.400 |
Why?
|
| Survival Rate | 15 | 2023 | 2151 | 0.390 |
Why?
|
| Pulmonary Valve | 4 | 2020 | 94 | 0.370 |
Why?
|
| Waiting Lists | 3 | 2022 | 242 | 0.370 |
Why?
|
| Cerebrovascular Circulation | 7 | 2018 | 487 | 0.370 |
Why?
|
| Thoracic Surgery | 1 | 2014 | 162 | 0.370 |
Why?
|
| Heart-Lung Transplantation | 1 | 2012 | 16 | 0.360 |
Why?
|
| Truncus Arteriosus, Persistent | 2 | 2021 | 19 | 0.340 |
Why?
|
| Multiple Organ Failure | 1 | 2012 | 143 | 0.320 |
Why?
|
| Heart Failure | 7 | 2023 | 2307 | 0.320 |
Why?
|
| Hydrocortisone | 4 | 2018 | 224 | 0.320 |
Why?
|
| Texas | 14 | 2020 | 3622 | 0.310 |
Why?
|
| Coronary Vessels | 4 | 2023 | 529 | 0.310 |
Why?
|
| Societies, Medical | 1 | 2014 | 794 | 0.310 |
Why?
|
| Septal Occluder Device | 1 | 2010 | 46 | 0.310 |
Why?
|
| Hypothermia, Induced | 7 | 2020 | 174 | 0.300 |
Why?
|
| Trachea | 3 | 2020 | 209 | 0.300 |
Why?
|
| Kidney Transplantation | 2 | 2012 | 572 | 0.280 |
Why?
|
| Aortic Valve Stenosis | 4 | 2024 | 354 | 0.280 |
Why?
|
| Thoracotomy | 3 | 2019 | 107 | 0.260 |
Why?
|
| Tachycardia, Supraventricular | 2 | 2022 | 110 | 0.260 |
Why?
|
| Computed Tomography Angiography | 2 | 2018 | 214 | 0.250 |
Why?
|
| Airway Obstruction | 2 | 2020 | 177 | 0.250 |
Why?
|
| Transportation of Patients | 1 | 2006 | 53 | 0.240 |
Why?
|
| Hospitals, Low-Volume | 2 | 2017 | 34 | 0.240 |
Why?
|
| Hospitals, Pediatric | 4 | 2018 | 794 | 0.240 |
Why?
|
| Natriuretic Peptide, Brain | 2 | 2024 | 326 | 0.240 |
Why?
|
| Tissue Donors | 3 | 2022 | 502 | 0.230 |
Why?
|
| Mitral Valve Stenosis | 1 | 2025 | 34 | 0.230 |
Why?
|
| Disasters | 1 | 2006 | 102 | 0.230 |
Why?
|
| Bioprinting | 1 | 2024 | 13 | 0.220 |
Why?
|
| Mitral Valve | 3 | 2020 | 249 | 0.220 |
Why?
|
| Spheroids, Cellular | 1 | 2024 | 60 | 0.220 |
Why?
|
| Young Adult | 18 | 2025 | 10104 | 0.210 |
Why?
|
| Prosthesis Design | 4 | 2020 | 612 | 0.210 |
Why?
|
| Truncus Arteriosus | 2 | 2021 | 13 | 0.210 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2024 | 105 | 0.210 |
Why?
|
| Ventricular Outflow Obstruction | 3 | 2014 | 84 | 0.210 |
Why?
|
| Anastomosis, Surgical | 4 | 2018 | 175 | 0.210 |
Why?
|
| Quality of Life | 1 | 2013 | 2118 | 0.200 |
Why?
|
| Homeostasis | 2 | 2018 | 713 | 0.200 |
Why?
|
| Thoracic Wall | 1 | 2023 | 41 | 0.200 |
Why?
|
| Twins, Conjoined | 1 | 2023 | 30 | 0.200 |
Why?
|
| Musculoskeletal Diseases | 1 | 2023 | 56 | 0.200 |
Why?
|
| Liver Transplantation | 1 | 2012 | 1131 | 0.190 |
Why?
|
| Nervous System | 2 | 2014 | 123 | 0.190 |
Why?
|
| Atrial Flutter | 1 | 2022 | 45 | 0.190 |
Why?
|
| Cell Survival | 1 | 2024 | 854 | 0.180 |
Why?
|
| Databases, Factual | 6 | 2019 | 1224 | 0.180 |
Why?
|
| Cardiomyopathy, Dilated | 2 | 2018 | 204 | 0.180 |
Why?
|
| Retreatment | 2 | 2020 | 87 | 0.180 |
Why?
|
| Filamins | 2 | 2021 | 26 | 0.170 |
Why?
|
| Recurrence | 4 | 2021 | 1483 | 0.170 |
Why?
|
| Risk Assessment | 10 | 2025 | 3695 | 0.170 |
Why?
|
| Age Factors | 9 | 2020 | 2872 | 0.170 |
Why?
|
| Tracheostomy | 2 | 2020 | 215 | 0.170 |
Why?
|
| Vascular Diseases | 1 | 2023 | 155 | 0.170 |
Why?
|
| Factor VIIa | 1 | 2020 | 21 | 0.170 |
Why?
|
| Tracheoesophageal Fistula | 2 | 2018 | 48 | 0.170 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2022 | 150 | 0.170 |
Why?
|
| Bronchi | 2 | 2018 | 102 | 0.170 |
Why?
|
| Cause of Death | 2 | 2017 | 510 | 0.160 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2020 | 20 | 0.160 |
Why?
|
| Aortic Arch Syndromes | 2 | 2014 | 11 | 0.160 |
Why?
|
| Postoperative Period | 5 | 2024 | 335 | 0.160 |
Why?
|
| Blood Flow Velocity | 3 | 2018 | 426 | 0.160 |
Why?
|
| Pierre Robin Syndrome | 1 | 2020 | 42 | 0.160 |
Why?
|
| Myocardial Ischemia | 1 | 2023 | 310 | 0.160 |
Why?
|
| Pneumonectomy | 1 | 2021 | 151 | 0.160 |
Why?
|
| Kaplan-Meier Estimate | 8 | 2017 | 1078 | 0.160 |
Why?
|
| Mandible | 1 | 2020 | 98 | 0.150 |
Why?
|
| Prospective Studies | 10 | 2024 | 6494 | 0.150 |
Why?
|
| Coronary Circulation | 3 | 2019 | 190 | 0.150 |
Why?
|
| Miniaturization | 1 | 2019 | 26 | 0.150 |
Why?
|
| Pulmonary Atresia | 1 | 2019 | 48 | 0.150 |
Why?
|
| Coronary Occlusion | 1 | 2019 | 30 | 0.150 |
Why?
|
| Brain Diseases | 2 | 2014 | 305 | 0.150 |
Why?
|
| Patient Readmission | 2 | 2021 | 423 | 0.150 |
Why?
|
| Heart Valve Diseases | 1 | 2020 | 174 | 0.150 |
Why?
|
| Heart Arrest | 1 | 2023 | 379 | 0.140 |
Why?
|
| Bronchial Diseases | 1 | 2018 | 11 | 0.140 |
Why?
|
| Adult | 17 | 2025 | 31719 | 0.140 |
Why?
|
| Sternotomy | 1 | 2018 | 42 | 0.140 |
Why?
|
| Developmental Disabilities | 2 | 2014 | 760 | 0.140 |
Why?
|
| Hospitalization | 5 | 2018 | 1939 | 0.130 |
Why?
|
| Monitoring, Intraoperative | 3 | 2017 | 130 | 0.130 |
Why?
|
| Esophageal Atresia | 1 | 2018 | 51 | 0.130 |
Why?
|
| Immunity, Humoral | 1 | 2018 | 76 | 0.130 |
Why?
|
| Myocardial Contraction | 4 | 2017 | 248 | 0.130 |
Why?
|
| Cardiotonic Agents | 2 | 2017 | 136 | 0.130 |
Why?
|
| Device Removal | 3 | 2015 | 223 | 0.130 |
Why?
|
| Arterial Pressure | 1 | 2018 | 131 | 0.130 |
Why?
|
| Cor Triatriatum | 1 | 2017 | 10 | 0.130 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2017 | 47 | 0.130 |
Why?
|
| Oxygen | 4 | 2018 | 552 | 0.130 |
Why?
|
| Atrial Septum | 1 | 2017 | 19 | 0.130 |
Why?
|
| Digestive System Abnormalities | 1 | 2017 | 38 | 0.130 |
Why?
|
| Stroke | 2 | 2023 | 1049 | 0.130 |
Why?
|
| Cystic Fibrosis | 2 | 2010 | 267 | 0.130 |
Why?
|
| Anemia, Sickle Cell | 1 | 2020 | 325 | 0.120 |
Why?
|
| Scoliosis | 1 | 2018 | 145 | 0.120 |
Why?
|
| Mitral Valve Insufficiency | 2 | 2009 | 183 | 0.120 |
Why?
|
| Intubation, Intratracheal | 2 | 2008 | 288 | 0.120 |
Why?
|
| Cardiac Output, Low | 2 | 2006 | 57 | 0.120 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2022 | 1006 | 0.120 |
Why?
|
| Ventricular Function, Right | 1 | 2017 | 126 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 865 | 0.120 |
Why?
|
| Bronchial Arteries | 1 | 2015 | 4 | 0.120 |
Why?
|
| Anesthetics | 2 | 2014 | 78 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2014 | 263 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 2017 | 201 | 0.120 |
Why?
|
| United States | 10 | 2024 | 11804 | 0.120 |
Why?
|
| History, 20th Century | 2 | 2014 | 366 | 0.110 |
Why?
|
| Registries | 3 | 2018 | 1599 | 0.110 |
Why?
|
| Atrial Fibrillation | 1 | 2022 | 733 | 0.110 |
Why?
|
| Hospitals, High-Volume | 1 | 2015 | 42 | 0.110 |
Why?
|
| Perfusion | 3 | 2012 | 210 | 0.110 |
Why?
|
| Respiratory Insufficiency | 1 | 2017 | 242 | 0.110 |
Why?
|
| Endocarditis, Bacterial | 1 | 2015 | 133 | 0.110 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2014 | 43 | 0.100 |
Why?
|
| Cohort Studies | 7 | 2020 | 5123 | 0.100 |
Why?
|
| Vena Cava, Superior | 2 | 2004 | 58 | 0.100 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2022 | 1263 | 0.100 |
Why?
|
| Proportional Hazards Models | 5 | 2018 | 1405 | 0.100 |
Why?
|
| Survival Analysis | 6 | 2017 | 1521 | 0.100 |
Why?
|
| Tetralogy of Fallot | 2 | 2018 | 176 | 0.100 |
Why?
|
| Williams Syndrome | 1 | 2012 | 43 | 0.090 |
Why?
|
| Hypertension, Pulmonary | 1 | 2017 | 463 | 0.090 |
Why?
|
| Multivariate Analysis | 5 | 2018 | 1405 | 0.090 |
Why?
|
| Erythropoietin | 1 | 2012 | 105 | 0.090 |
Why?
|
| Hemodynamics | 5 | 2018 | 816 | 0.090 |
Why?
|
| Hospital Charges | 1 | 2012 | 65 | 0.090 |
Why?
|
| Protein-Losing Enteropathies | 1 | 2011 | 19 | 0.090 |
Why?
|
| Donor Selection | 1 | 2012 | 58 | 0.090 |
Why?
|
| Lymphoproliferative Disorders | 2 | 2012 | 218 | 0.090 |
Why?
|
| Neuroprotective Agents | 1 | 2012 | 161 | 0.080 |
Why?
|
| Death, Sudden, Cardiac | 2 | 2023 | 273 | 0.080 |
Why?
|
| Pulmonary Subvalvular Stenosis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2012 | 176 | 0.080 |
Why?
|
| Cattle | 3 | 2021 | 521 | 0.080 |
Why?
|
| Education, Medical | 1 | 2014 | 288 | 0.080 |
Why?
|
| Heart Arrest, Induced | 4 | 2004 | 74 | 0.080 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 2 | 2012 | 113 | 0.080 |
Why?
|
| Comorbidity | 5 | 2017 | 1600 | 0.080 |
Why?
|
| Child Development | 1 | 2012 | 272 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2016 | 3917 | 0.080 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2010 | 92 | 0.080 |
Why?
|
| Nontuberculous Mycobacteria | 1 | 2009 | 25 | 0.070 |
Why?
|
| Biomarkers | 4 | 2024 | 3405 | 0.070 |
Why?
|
| Incidence | 5 | 2018 | 3347 | 0.070 |
Why?
|
| Mycobacterium Infections, Nontuberculous | 1 | 2009 | 46 | 0.070 |
Why?
|
| Agammaglobulinemia | 1 | 2008 | 43 | 0.070 |
Why?
|
| Sternum | 1 | 2008 | 50 | 0.070 |
Why?
|
| Nervous System Diseases | 1 | 2012 | 403 | 0.070 |
Why?
|
| Cardiac Catheterization | 3 | 2019 | 635 | 0.070 |
Why?
|
| Oxygen Consumption | 4 | 2010 | 301 | 0.070 |
Why?
|
| Blood Vessel Prosthesis | 2 | 2015 | 472 | 0.070 |
Why?
|
| Postoperative Care | 4 | 2010 | 303 | 0.070 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2015 | 742 | 0.070 |
Why?
|
| Organophosphonates | 1 | 2007 | 21 | 0.070 |
Why?
|
| Cytosine | 1 | 2007 | 53 | 0.070 |
Why?
|
| Prosthesis Failure | 2 | 2020 | 148 | 0.070 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2024 | 127 | 0.070 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2019 | 676 | 0.070 |
Why?
|
| Hospital Costs | 2 | 2019 | 180 | 0.060 |
Why?
|
| Treatment Failure | 3 | 2019 | 353 | 0.060 |
Why?
|
| Hemoglobin SC Disease | 1 | 2007 | 7 | 0.060 |
Why?
|
| Transplantation Immunology | 1 | 2007 | 40 | 0.060 |
Why?
|
| Adenovirus Infections, Human | 1 | 2007 | 60 | 0.060 |
Why?
|
| Tricuspid Atresia | 1 | 2007 | 14 | 0.060 |
Why?
|
| Gestational Age | 2 | 2022 | 1221 | 0.060 |
Why?
|
| Global Health | 1 | 2012 | 632 | 0.060 |
Why?
|
| Swine | 6 | 2015 | 1190 | 0.060 |
Why?
|
| Lung | 3 | 2022 | 1565 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2017 | 1344 | 0.060 |
Why?
|
| Monitoring, Physiologic | 3 | 2018 | 371 | 0.060 |
Why?
|
| Pericardium | 1 | 2007 | 105 | 0.060 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 174 | 0.060 |
Why?
|
| Pulmonary Circulation | 2 | 2021 | 114 | 0.060 |
Why?
|
| Patient Transfer | 1 | 2006 | 110 | 0.060 |
Why?
|
| Immunocompromised Host | 1 | 2007 | 313 | 0.060 |
Why?
|
| Electroencephalography | 1 | 2010 | 869 | 0.060 |
Why?
|
| Poloxamer | 1 | 2024 | 14 | 0.060 |
Why?
|
| Porosity | 1 | 2024 | 43 | 0.060 |
Why?
|
| Alginates | 1 | 2024 | 23 | 0.060 |
Why?
|
| Patient Selection | 1 | 2008 | 726 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3834 | 0.050 |
Why?
|
| Seizures | 1 | 2010 | 889 | 0.050 |
Why?
|
| Aortic Diseases | 1 | 2006 | 189 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2006 | 252 | 0.050 |
Why?
|
| Hospitals | 2 | 2021 | 445 | 0.050 |
Why?
|
| Salvage Therapy | 1 | 2005 | 178 | 0.050 |
Why?
|
| Heart Rate | 2 | 2005 | 580 | 0.050 |
Why?
|
| Allografts | 2 | 2015 | 209 | 0.050 |
Why?
|
| Printing, Three-Dimensional | 1 | 2024 | 88 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2018 | 3454 | 0.050 |
Why?
|
| Cadaver | 1 | 2023 | 121 | 0.050 |
Why?
|
| Brain | 5 | 2014 | 3239 | 0.050 |
Why?
|
| Ribs | 1 | 2023 | 55 | 0.050 |
Why?
|
| Prognosis | 3 | 2017 | 4952 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2005 | 303 | 0.050 |
Why?
|
| Transplantation, Heterologous | 2 | 1994 | 261 | 0.050 |
Why?
|
| Animals, Newborn | 5 | 1994 | 1024 | 0.050 |
Why?
|
| Perioperative Period | 2 | 2014 | 51 | 0.050 |
Why?
|
| Linear Models | 2 | 2018 | 695 | 0.050 |
Why?
|
| Tachycardia | 1 | 2022 | 71 | 0.050 |
Why?
|
| Blood | 2 | 1994 | 100 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2007 | 378 | 0.050 |
Why?
|
| Animals | 11 | 2024 | 34375 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2017 | 432 | 0.050 |
Why?
|
| Antiviral Agents | 1 | 2007 | 812 | 0.040 |
Why?
|
| Middle Aged | 5 | 2025 | 28889 | 0.040 |
Why?
|
| Ventricular Dysfunction, Left | 3 | 2011 | 359 | 0.040 |
Why?
|
| Morphine | 1 | 2022 | 80 | 0.040 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2017 | 493 | 0.040 |
Why?
|
| Bronchoscopy | 2 | 2015 | 179 | 0.040 |
Why?
|
| Methadone | 1 | 2022 | 126 | 0.040 |
Why?
|
| Acetaminophen | 1 | 2022 | 97 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 2 | 2014 | 133 | 0.040 |
Why?
|
| Morbidity | 1 | 2021 | 261 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2024 | 536 | 0.040 |
Why?
|
| Fetal Heart | 1 | 2022 | 135 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2022 | 172 | 0.040 |
Why?
|
| Replantation | 1 | 2020 | 52 | 0.040 |
Why?
|
| Micrognathism | 1 | 2020 | 65 | 0.040 |
Why?
|
| Cardioplegic Solutions | 2 | 1991 | 18 | 0.040 |
Why?
|
| Immunosuppressive Agents | 3 | 2008 | 667 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2008 | 517 | 0.040 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 570 | 0.040 |
Why?
|
| Osteogenesis, Distraction | 1 | 2020 | 69 | 0.040 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 997 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2024 | 2971 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2017 | 2120 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 2018 | 670 | 0.040 |
Why?
|
| Blood Pressure Determination | 1 | 2018 | 119 | 0.030 |
Why?
|
| Constriction, Pathologic | 1 | 2018 | 228 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 147 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 1316 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2021 | 506 | 0.030 |
Why?
|
| Acute Disease | 2 | 2018 | 1153 | 0.030 |
Why?
|
| Infant, Premature | 2 | 2017 | 856 | 0.030 |
Why?
|
| Coronary Angiography | 1 | 2019 | 457 | 0.030 |
Why?
|
| Oximetry | 1 | 2018 | 177 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 470 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2018 | 262 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2020 | 1454 | 0.030 |
Why?
|
| Fatal Outcome | 2 | 2009 | 364 | 0.030 |
Why?
|
| Reference Values | 1 | 2017 | 692 | 0.030 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2012 | 481 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 195 | 0.030 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 1997 | 342 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 1997 | 834 | 0.030 |
Why?
|
| Respiration, Artificial | 1 | 1997 | 501 | 0.030 |
Why?
|
| Swine, Miniature | 1 | 1994 | 55 | 0.030 |
Why?
|
| Sex Factors | 1 | 2018 | 1346 | 0.030 |
Why?
|
| Receptors, Complement | 1 | 1994 | 31 | 0.030 |
Why?
|
| Blood Gas Analysis | 1 | 1994 | 88 | 0.030 |
Why?
|
| Critical Care | 2 | 2010 | 680 | 0.030 |
Why?
|
| Cold Temperature | 1 | 1994 | 81 | 0.030 |
Why?
|
| Equipment Design | 2 | 2006 | 555 | 0.030 |
Why?
|
| Disease-Free Survival | 1 | 2015 | 910 | 0.030 |
Why?
|
| Ultrasonography | 2 | 2009 | 974 | 0.030 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 251 | 0.020 |
Why?
|
| Preoperative Care | 2 | 2006 | 358 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2014 | 178 | 0.020 |
Why?
|
| Inhalation | 1 | 2012 | 8 | 0.020 |
Why?
|
| Partial Pressure | 1 | 2012 | 27 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2012 | 241 | 0.020 |
Why?
|
| Databases as Topic | 1 | 2012 | 75 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4516 | 0.020 |
Why?
|
| Plasma Substitutes | 1 | 1991 | 7 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2012 | 157 | 0.020 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2011 | 65 | 0.020 |
Why?
|
| Brain Ischemia | 1 | 1993 | 261 | 0.020 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2012 | 226 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 111 | 0.020 |
Why?
|
| Potassium Compounds | 1 | 1988 | 7 | 0.020 |
Why?
|
| Pregnancy | 1 | 2022 | 7572 | 0.020 |
Why?
|
| Bronchoalveolar Lavage | 1 | 2008 | 22 | 0.020 |
Why?
|
| Drainage | 1 | 2010 | 253 | 0.020 |
Why?
|
| Video Recording | 1 | 2010 | 208 | 0.020 |
Why?
|
| Sputum | 1 | 2009 | 118 | 0.020 |
Why?
|
| Cyclosporine | 1 | 2008 | 129 | 0.020 |
Why?
|
| Transplantation, Autologous | 1 | 2008 | 269 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 213 | 0.020 |
Why?
|
| Contraindications | 1 | 2008 | 77 | 0.020 |
Why?
|
| Assisted Circulation | 1 | 2007 | 22 | 0.020 |
Why?
|
| Immunoglobulin A | 1 | 2008 | 210 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 1993 | 785 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2015 | 1052 | 0.020 |
Why?
|
| Bronchiolitis Obliterans | 1 | 2008 | 42 | 0.020 |
Why?
|
| Mutation | 1 | 2021 | 6177 | 0.020 |
Why?
|
| Decompression, Surgical | 1 | 2008 | 89 | 0.020 |
Why?
|
| Anesthesia | 1 | 2010 | 210 | 0.020 |
Why?
|
| Sepsis | 1 | 2012 | 501 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 990 | 0.020 |
Why?
|
| Risk | 1 | 2009 | 739 | 0.020 |
Why?
|
| Viral Load | 1 | 2008 | 406 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2007 | 235 | 0.020 |
Why?
|
| Situs Inversus | 1 | 2006 | 26 | 0.020 |
Why?
|
| Probability | 1 | 2007 | 310 | 0.020 |
Why?
|
| Electrocardiography | 1 | 2012 | 983 | 0.020 |
Why?
|
| Herpesvirus 4, Human | 1 | 2008 | 646 | 0.010 |
Why?
|
| Logistic Models | 1 | 2010 | 1831 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 810 | 0.010 |
Why?
|
| Hemothorax | 1 | 2005 | 17 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2007 | 254 | 0.010 |
Why?
|
| Prevalence | 1 | 2012 | 2694 | 0.010 |
Why?
|
| Equipment Failure Analysis | 1 | 2005 | 84 | 0.010 |
Why?
|
| Disease Progression | 1 | 2011 | 2206 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2005 | 228 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 1911 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 2297 | 0.010 |
Why?
|
| Ventricular Pressure | 1 | 2004 | 36 | 0.010 |
Why?
|
| Dilatation, Pathologic | 1 | 2004 | 80 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 2567 | 0.010 |
Why?
|
| Aged | 2 | 2012 | 21261 | 0.010 |
Why?
|
| Ultrasonography, Doppler | 1 | 2004 | 184 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2004 | 244 | 0.010 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2004 | 122 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 6925 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3101 | 0.010 |
Why?
|
| Cardiomyopathies | 1 | 2005 | 516 | 0.010 |
Why?
|
| Sheep | 2 | 1991 | 225 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2006 | 1306 | 0.010 |
Why?
|
| Models, Biological | 2 | 1994 | 1392 | 0.010 |
Why?
|
| Myocardium | 2 | 1991 | 874 | 0.010 |
Why?
|
| Antibodies, Heterophile | 1 | 1994 | 8 | 0.010 |
Why?
|
| Haplorhini | 1 | 1994 | 106 | 0.010 |
Why?
|
| Temperature | 1 | 1994 | 294 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1994 | 312 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 1993 | 824 | 0.010 |
Why?
|
| Isotonic Solutions | 1 | 1991 | 37 | 0.010 |
Why?
|
| Body Water | 1 | 1991 | 88 | 0.010 |
Why?
|
| Biopsy | 1 | 1994 | 1252 | 0.000 |
Why?
|
| Cyanosis | 1 | 1988 | 42 | 0.000 |
Why?
|
| Potassium | 1 | 1988 | 270 | 0.000 |
Why?
|